Simple Summary Interventional radiology image-guided locoregional therapies for the
treatment of HCC have demonstrated to be characterized by immunomodulatory effects on …

Image-guided locoregional therapies (LRTs) have long been a vital part of treatment
regimens for hepatocellular carcinoma (HCC). Ablation, chemoembolization, and …

Locoregional therapies are commonly used to treat patients with hepatocellular carcinoma. It
has been noted for many years that locoregional therapies may have additional systemic …

Locoregional and systemic therapies are the most used treatment options for patients with
hepatocellular carcinoma (HCC). Interventional radiologists have improved and developed …

Interventional oncology (IO) local therapies of hepatocellular carcinoma (HCC) can activate
anti-cancer immunity and it is potentially leading to an anti-cancer immunity throughout the …

Simple Summary Liver cancer continues to exhibit increasing incidence and mortality
worldwide. Subsequently, there has been a concomitant effort to development novel …

Locoregional therapies (LRTs) including radiofrequency ablation, surgical resection, and
TACE, play a pivotal role in the treatment of early stage/locally advanced hepatocellular …

Immunotherapy has remarkably revolutionized the management of advanced HCC and
prompted clinical trials, with therapeutic agents being used to selectively target immune cells …

Hepatocellular carcinoma (HCC) was the sixth most common cancer and the third cause of
cancer-related deaths worldwide in 2020. Liver resection and transplantation remain the …

Background Immunotherapy represents a promising option for treatment of hepatocellular
carcinoma (HCC) in cirrhotic patients but its efficacy is currently inconsistent and …